226 related articles for article (PubMed ID: 23135805)
21. Ifosfamide induced encephalopathy following chemotherapy of Non-Hodgkin's Lymphoma.
Jain S; Moger V; Kumari S; Varma S
Neurol India; 2001 Dec; 49(4):416. PubMed ID: 11799423
[No Abstract] [Full Text] [Related]
22. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.
Küpfer A; Aeschlimann C; Cerny T
Eur J Clin Pharmacol; 1996; 50(4):249-52. PubMed ID: 8803513
[TBL] [Abstract][Full Text] [Related]
23. Ifosfamide-induced encephalopathy and movement disorder.
Ames B; Lewis LD; Chaffee S; Kim J; Morse R
Pediatr Blood Cancer; 2010 Apr; 54(4):624-6. PubMed ID: 19953647
[TBL] [Abstract][Full Text] [Related]
24. Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Brunello A; Basso U; Rossi E; Stefani M; Ghiotto C; Marino D; Crivellari G; Monfardini S
Drugs Aging; 2007; 24(11):967-73. PubMed ID: 17953463
[TBL] [Abstract][Full Text] [Related]
25. Methylene blue and ifosfamide-induced encephalopathy: Myth or reality?
Abahssain H; Moukafih B; Essangri H; Mrabti H; Meddah B; Guessous F; Fadhil FZ; Souadka A; Errihani H
J Oncol Pharm Pract; 2021 Jan; 27(1):143-149. PubMed ID: 33153383
[TBL] [Abstract][Full Text] [Related]
26. Evaluating risk factors for the development of ifosfamide encephalopathy.
David KA; Picus J
Am J Clin Oncol; 2005 Jun; 28(3):277-80. PubMed ID: 15923801
[TBL] [Abstract][Full Text] [Related]
27. Ifosfamide neuropsychiatric toxicity in patients with cancer.
Alici-Evcimen Y; Breitbart WS
Psychooncology; 2007 Oct; 16(10):956-60. PubMed ID: 17278152
[TBL] [Abstract][Full Text] [Related]
28. Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.
Snyder M; Gangadhara S; Brohl AS; Ludlow S; Nanjappa S
Cancer Control; 2017; 24(5):1073274817729070. PubMed ID: 28975823
[TBL] [Abstract][Full Text] [Related]
29. Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity.
Giovanis P; Garna A; Marcante M; Nardi K; Giusto M
Tumori; 2009; 95(4):545-6. PubMed ID: 19856674
[TBL] [Abstract][Full Text] [Related]
30. Ifosfamide in the treatment of pediatric malignancies.
Voûte PA; van den Berg H; Behrendt H; Michiels E; de Kraker J
Semin Oncol; 1996 Jun; 23(3 Suppl 7):8-11. PubMed ID: 8711502
[TBL] [Abstract][Full Text] [Related]
31. Ifosfamide encephalopathy: a case report.
Pavarana M; Nortilli R; Valcamonico F; Romito S; Zanoni T; Cetto G
Tumori; 2005; 91(2):197-200. PubMed ID: 15948552
[TBL] [Abstract][Full Text] [Related]
32. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Sweiss KI; Beri R; Shord SS
Drug Saf; 2008; 31(11):989-96. PubMed ID: 18840018
[TBL] [Abstract][Full Text] [Related]
33. Ifosfamide encephalopathy.
Ajithkumar T; Parkinson C; Shamshad F; Murray P
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):108-14. PubMed ID: 17355105
[TBL] [Abstract][Full Text] [Related]
34. Nonconvulsive status epilepticus due to ifosfamide.
Kilickap S; Cakar M; Onal IK; Tufan A; Akoglu H; Aksoy S; Erman M; Tekuzman G
Ann Pharmacother; 2006 Feb; 40(2):332-5. PubMed ID: 16449538
[TBL] [Abstract][Full Text] [Related]
35. Green urine secondary to methylene blue.
Miri-Aliabad G
Indian J Pediatr; 2014 Nov; 81(11):1255-6. PubMed ID: 24794328
[No Abstract] [Full Text] [Related]
36. Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy.
McDonnell AM; Rybak I; Wadleigh M; Fisher DC
J Oncol Pharm Pract; 2012 Dec; 18(4):436-9. PubMed ID: 22235061
[TBL] [Abstract][Full Text] [Related]
37. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
Liu YL; Tsai SH; Chang FW; Yu MH
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
[TBL] [Abstract][Full Text] [Related]
38. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
Pratt CB
Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
[TBL] [Abstract][Full Text] [Related]
39. [Syndrome of inappropriate secretion of antidiuretic hormone and neurotoxicity induced by vincristine and alkylating agents during chemotherapy for malignant lymphoma of thyroid gland].
Tsujita Y; Iwao N; Makino S; Ohsawa N
Gan To Kagaku Ryoho; 1998 Apr; 25(5):757-60. PubMed ID: 9571977
[TBL] [Abstract][Full Text] [Related]
40. Suspected ifosfamide-induced neurotoxicity.
McVay JI; Wood AM
Pharmacotherapy; 1999 Dec; 19(12):1450-5. PubMed ID: 10600096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
